What they were paid
Vertex Pharmaceuticals Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $135,000 | $400,364 | — | $25,000 | $560,364 |
| FY2024 | $135,000 | $400,110 | — | $15,000 | $550,110 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Vertex Pharmaceuticals Inc DEF 14A filed April 2, 2026, accession 0000875320-26-000153, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Vertex Pharmaceuticals pays directors a $100,000 cash retainer and $400,000 in Options and/or RSUs (director elects fully-vested options, 1-yr vesting RSUs, or 50/50 mix).
Committees
FY2025 · as the proxy prints themNominating/Governance · Science and Technology (Chair)
The rest of the Vertex Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alan Garber | Independent Director | $545,247 |
| Bruce I. Sachs | Lead Independent Director | $615,130 |
| Diana McKenzie | Independent Director | $552,864 |
| Jeffrey Leiden | Chair of the Board | $0 |
| Jennifer Schneider | Independent Director | $537,864 |
| Lloyd Carney | Independent Director | $565,364 |
| Michel Lagarde | Independent Director | $540,130 |
| Nancy Thornberry | Independent Director | $528,247 |
| Reshma Kewalramani | Director | $0 |
| Suketu Upadhyay | Independent Director | $565,864 |
The full Vertex Pharmaceuticals compensation record
free company briefThis page is one director within Vertex Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat